CorticotropinHormone-based prescription preparation
Corticotropin, or ACTH, signals the adrenal glands to produce steroids. Medical preparations have been used in specific neurological and inflammatory conditions, with effects and risks that require careful clinical context.
What is Corticotropin?
Corticotropin is adrenocorticotropic hormone (ACTH), a pituitary hormone that stimulates adrenal hormone production. Therapeutic preparations have been used in conditions including infantile spasms and selected inflammatory disorders. 1 2
How it works
ACTH stimulates the adrenal cortex to produce corticosteroids, including cortisol. Preparation and duration influence the resulting exposure and clinical effects. 2
Effects studied
What does the evidence show?
Indication-specific clinical use; archived trial and label retained
The pituitary–adrenal connection
ACTH is a hormone normally released by the pituitary. It stimulates the adrenal cortex, including production of cortisol. Corticotropin preparations use this biology therapeutically. Their composition and duration of action are part of the product, so describing them simply as the natural hormone leaves out relevant detail.
Why the indication matters
The archive includes uses such as infantile spasms and selected inflammatory conditions. Evidence in a severe infant seizure disorder cannot be applied automatically to multiple sclerosis, kidney disease or another condition. The clinical comparison may also involve corticosteroids or other established treatments, not just placebo.
More than a mechanism comparison
Stimulating endogenous steroid production and administering a steroid directly are different interventions, but that does not establish that one is safer or better. Potential actions at other melanocortin receptors are an additional research question. The clinical outcome in the condition being treated is what matters.
Steroid-like effects still need attention
Infection susceptibility, changes in blood glucose, fluid retention, blood pressure and adrenal suppression are relevant concerns. In children, growth and development also matter. These effects explain why treatment decisions and discontinuation require supervision. Therapeutic corticotropin preparations also differ from cosyntropin used in diagnostic testing. Their medical uses do not make increasing ACTH a useful wellness goal.
Safety & status
Effects can include increased infection risk, changes in glucose, blood pressure and fluid balance, and adrenal suppression. Growth is a particular consideration in children; treatment withdrawal requires clinical supervision. 2
Country and product status
Country-specific product availability and authorisation require a separate current check.
Frequently asked questions
Is it the same as a cosyntropin test?
No. Cosyntropin is a shorter synthetic ACTH fragment commonly used for diagnostic stimulation testing; therapeutic corticotropin has a different purpose.
Are its effects limited to the target condition?
No. Stimulating corticosteroid production can have wider metabolic, immune and fluid-balance effects. 2
Further reading
Sources
This entry was rewritten from our research archive. References below are reading leads unless a completed check is explicitly noted; a full independent evidence and regulatory review is still pending.
- Corticotropin · retained archive reference Archive research lead · Retained archive reference; not independently checked for this draft
- Corticotropin · retained archive reference Archive research lead · Retained archive reference; not independently checked for this draft
Research provenance
This name was discovered in the Superpower peptide index, archived 26 October 2026. Its ratings and reviewer attribution have not been adopted as our own. The archive informed this original editorial draft; independent source review is still pending.